塞力斯医疗科技集团股份有限公司 控股股东、实际控制人行为规范 第三条 控股股东、实际控制人应当遵守诚实信用原则，依法行使股东权利、 履行股东义务，依规签署并恪守有关声明和承诺，不得隐瞒其控股股东、实际控 制人身份，逃避相关义务和责任。 第四条 控股股东、实际控制人应当维护公司独立性，不得滥用股东权利、 控制地位或者利用关联关系损害公司和其他股东的合法权益，不得利用对公司的 控制地位牟取非法利益。 公司的控股股东、实际控制人不担任公司董事但实际执行公司事务的，对公 司负有忠实义务、勤勉义务。 第二章 公司治理 塞力斯医疗科技集团股份有限公司 控股股东、实际控制人行为规范 （2025年8月） 第一章 总则 第一条 为进一步完善塞力斯医疗科技集团股份有限公司(以下简称"公 司")的法人治理结构，规范控股股东、实际控制人对公司的行为，保护公司和 股东的合法权益。根据《中华人民共和国公司法》《中华人民共和国证券法》《上 市公司治理准则》《上海证券交易所股票上市规则》《上海证券交易所上市公司 自律监管指引第 1 号——规范运作》等法律、法规、规章、规范性文件及《塞力 斯医疗科技集团股份有限公司章程》（以下简称"《公司章程 ...

Core Viewpoint - The document outlines the regulations governing the behavior of the controlling shareholders and actual controllers of Anhui Juyi Technology Co., Ltd., aiming to enhance corporate governance and ensure the company's healthy development [1]. Group 1: General Principles - The regulations are established to ensure that controlling shareholders and actual controllers act in good faith and in accordance with laws and the company's articles of association [1][2]. - Controlling shareholders and actual controllers must not abuse their rights to harm the interests of the company and other shareholders [1][2]. Group 2: Corporate Governance - Controlling shareholders and actual controllers are required to maintain the company's independence and ensure the integrity of its assets, personnel, finances, institutions, and operations [2][3]. - They must not infringe upon the company's rights to its assets and must handle asset transfers in accordance with legal and contractual obligations [2][3]. - Measures must be taken to prevent conflicts of interest and ensure independent decision-making in personnel, financial, and operational matters [3][4][5]. Group 3: Information Disclosure - Controlling shareholders and actual controllers must designate responsible personnel for information disclosure and cooperate with the company's disclosure obligations [6][7]. - They are required to notify the company of significant events that may impact the company's securities and cooperate in the disclosure process [6][7]. - Confidentiality of undisclosed significant information must be maintained, and any media reports that could affect the company's securities must be promptly addressed [8][9]. Group 4: Share Trading and Control Transfer - Controlling shareholders and actual controllers must comply with legal regulations when trading company shares and maintain control stability [10][11]. - Any transfer of control must be fair and reasonable, ensuring that the rights of the company and other shareholders are not compromised [10][11]. - Prior to transferring control, due diligence on the transferee's qualifications and intentions is required to ensure a fair transaction [10][11]. Group 5: Other Provisions - Controlling shareholders and actual controllers must ensure that their commitments are enforceable and provide guarantees for commitments with significant performance risks [12][13]. - The document is subject to daily supervision by the securities exchange and requires compliance with relevant laws and regulations [13].

润本生物技术股份有限公司 第一章 总则 第一条 为进一步规范润本生物技术股份有限公司（"公司"）控股股东、实 际控制人的行为，保护广大股东特别是中小股东权益不受损害，根据《中华人民 共和国公司法》《中华人民共和国证券法》《上海证券交易所股票上市规则》《上 海证券交易所上市公司自律监管指引第 1 号——规范运作》法律、行政法规、规 （以下称"《公司章程》"） 章、规范性文件以及《润本生物技术股份有限公司章程》 的有关规定，制定本规范。 第二条 本规范所称控股股东是其持有的股份占股份有限公司股本总额超 过百分之五十的股东；或者持有股份的比例虽然未超过百分之五十，但其持有的 股份所享有的表决权已足以对股东会的决议产生重大影响的股东。 第三条 本规范所称实际控制人是指通过投资关系、协议或者其他安排，能 够实际控制、影响公司行为的自然人、法人或其他组织。 （二）依法行使股东权利，不滥用控制权损害公司或者其他股东的合法权益； 第四条 下列主体的行为视同控股股东、实际控制人行为，适用本规范的相 关规定： （一）控股股东、实际控制人直接或间接控制的法人、非法人组织（公司及 公司控股子公司除外）； （二）控股股东、实际控制人为 ...

Core Points - The document outlines the behavior norms for the controlling shareholders and actual controllers of Guangzhou Weili Medical Equipment Co., Ltd, aiming to protect the rights and interests of the company and its shareholders [2][3][4] Group 1: General Principles - The norms are established based on relevant laws and regulations, including the Company Law and Securities Law, to guide the actions of controlling shareholders and actual controllers [2] - The controlling shareholders and actual controllers must exercise their rights and fulfill their obligations in accordance with laws and regulations, ensuring the interests of the listed company are maintained [2][4] Group 2: Responsibilities and Conduct - Controlling shareholders and actual controllers are prohibited from abusing their control rights or harming the legitimate rights of the company and other shareholders [4][5] - They must strictly adhere to public statements and commitments made, and cannot unilaterally change or waive them [4][5] - They are required to fulfill information disclosure obligations and promptly inform the company of any significant events [4][5] - They must not occupy company funds in any manner or compel the company to provide illegal guarantees [4][5][6] - Engaging in insider trading, short-term trading, or market manipulation is strictly forbidden [4][5][6] Group 3: Independence and Governance - The document emphasizes the importance of maintaining the independence of the company’s assets, personnel, finances, and operations [5][6] - Controlling shareholders and actual controllers must not interfere with the independent operation of the company's board, audit committee, or other departments [6][7] - They are required to support the establishment of an independent business model and avoid any competition that may harm the company's interests [6][7] Group 4: Information Disclosure - Controlling shareholders and actual controllers must ensure that all disclosed information is truthful, accurate, complete, timely, and fair [10][11] - They are responsible for notifying the company of any significant changes in their shareholding or control status [11][12] - Confidentiality of undisclosed significant information must be maintained, and any leaks must be reported immediately [11][12] Group 5: Share Transfer and Control Stability - Any transfer of shares that may lead to a change in control must be fair, reasonable, and not harm the interests of the company or other shareholders [12][13] - Controlling shareholders and actual controllers must maintain control stability and assess risks associated with stock pledges [12][13] Group 6: Compliance and Accountability - The document mandates that controlling shareholders and actual controllers must comply with all relevant laws and regulations, and they are accountable for any violations [15][16] - They must provide guarantees for commitments with significant performance risks and inform the company of any changes affecting these guarantees [14][15]

广州安凯微电子股份有限公司 控股股东、实际控制人行为规范 第一章 总则 第一条 为进一步完善广州安凯微电子股份有限公司（以下简称"公司"） 的法人治理结构，规范控股股东、实际控制人对公司的行为，根据《中华人民共 和国公司法》（以下简称"《公司法》"）、《中华人民共和国证券法》（以下 简称"《证券法》"）、《上市公司治理准则》等法律、法规及规范性文件及《广 州安凯微电子股份有限公司章程》（以下简称"《公司章程》"）的规定，制定 本规范。 第二条 本规范适用于公司控股股东、实际控制人及其关联方的行为和信息 披露等相关工作。本规范中对控股股东、实际控制人的所有规定，均同样适用于 其关联方。 第三条 本规范所称控股股东，是指具备下列条件之一的股东： （一）直接持有公司股本总额50%以上的股东； （二）持有股份的比例虽然不足50%，但依其持有的股份所享有的表决权已 足以对股东会的决议产生重大影响的股东； （三）中国证监会、证券交易所认定的其他情形。 第四条 本规范所称实际控制人，是指通过投资关系、协议或者其他安排， 能够实际支配公司行为的自然人或法人。具有下列情形之一的，构成控制： （一）持有公司 50%以上的股份，但 ...

二○二五年八月 浙江嘉化能源化工股份有限公司 控股股东、实际控制人行为规范 第一章 总 则 第一条 为引导和规范浙江嘉化能源化工股份有限公司（以下简称"公司"） 控股股东、实际控制人的行为，切实保护公司和其他股东的合法权益，根据《中 华人民共和国公司法》《中华人民共和国证券法》（以下简称"《证券法》"）、 《上市公司治理准则》《上海证券交易所股票上市规则》（以下简称"《股票上 市规则》"）《上海证券交易所上市公司自律监管指引第 1 号——规范运作》等 法律、法规、规范性文件以及《浙江嘉化能源化工股份有限公司章程》（以下简 称"《公司章程》"）等相关规定，并结合公司的实际情况，特制定本规范。 第二条 控股股东、实际控制人及其相关人员应当遵守证券市场有关法律法 规的规定，促进公司规范运作，提高公司质量。 第三条 控股股东、实际控制人应当依照法律、行政法规、中国证监会和证 券交易所的规定行使权利、履行义务，维护上市公司利益。 第四条 控股股东、实际控制人不得通过关联交易、资产重组、对外投资、 担保、利润分配和其他方式直接或者间接侵占上市公司资金、资产，损害公司及 其他股东的利益。 浙江嘉化能源化工股份有限公司 控股 ...

华平信息技术股份有限公司 控股股东、实际控制人行为规范 华平信息技术股份有限公司 第一章 总则 第一条 为贯彻证券市场公开、公平、公正原则，进一步完善华平信息技术 股份有限公司(以下简称"公司")的法人治理结构，规范控股股东、实际控制人 行为，切实保护公司和中小股东的合法权益，根据《中华人民共和国公司法》 第四条 本规范所称实际控制人，是指通过投资关系、协议或者其他安排， 能够实际支配公司行为的自然人、法人或者其他组织。 第五条 以下主体的行为视同控股股东、实际控制人行为，适用本规范相关 规定： 华平信息技术股份有限公司 控股股东、实际控制人行为规范 《中 华人民共和国证券法》 （以下简称《证券法》） 《上市公司治理准则(2025 修正)》 《深圳证券交易所创业板股票上市规则（2025 年修订）》（以下简称《上市规 则》）《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范 运作（2025 年修订）》（以下简称《规范运作指引》）、《深圳证券交易所上 市公司自律监管指引第 18 号——股东及董事、高级管理人员减持股份（2025 修 订）》（以下简称《减持指引》）等法律、法规、部门规章、规范性文件 ...

Core Viewpoint - The document outlines the governance and operational guidelines for Chongyi Zhangyuan Tungsten Co., Ltd, focusing on the responsibilities and obligations of controlling shareholders and actual controllers to ensure the protection of the company's and minority shareholders' rights [1][2][3]. Group 1: General Principles - Controlling shareholders must exercise their rights and fulfill obligations in accordance with laws and regulations, avoiding actions that harm the company or other shareholders' interests [5][6]. - Shareholders and actual controllers are required to maintain confidentiality regarding undisclosed significant information and refrain from insider trading or market manipulation [6][7]. - Major decisions of the company should be made by the shareholders' meeting and board of directors, without interference from controlling shareholders [9][10]. Group 2: Commitment and Good Faith - Controlling shareholders and actual controllers must make clear, specific, and enforceable commitments, ensuring compliance with laws and regulations [10][11]. - They are responsible for protecting the rights of minority shareholders and must not restrict their legitimate rights [12][13]. - Any misuse of control to gain illegal benefits is prohibited, and they must adhere to the company's articles of association [11][12]. Group 3: Independence Requirements - There must be a clear separation of personnel, assets, and finances between the controlling shareholders and the company to maintain operational independence [15][16]. - The company’s management should operate independently from the controlling shareholders, ensuring that no undue influence is exerted on personnel decisions [16][17]. - Controlling shareholders must not interfere with the company's financial activities or use company assets for personal gain [18][19]. Group 4: Information Disclosure - Controlling shareholders and actual controllers are required to cooperate with the company in fulfilling information disclosure obligations, ensuring that all disclosed information is accurate and complete [29][30]. - They must establish a management system for information disclosure, including protocols for handling undisclosed significant information [31][32]. - Any changes in shareholding or control that could impact the company must be promptly communicated to ensure transparency [33][34].